Company / Current Assets
Olema Pharmaceuticals, Inc. Current Assets History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$438.5M
FY2024
5-year range
$208.9M / $438.5M
FY2020-FY2024
Trend
+64.5%
vs FY2023
Sector context
#126 of 213
Health Care
What the data says
At $438M, Olema Pharmaceuticals, Inc.'s current assets ranks #126 of 213 in the Health Care sector. Improved from $209M to $438M over the past 2 years.
Based on SEC 10-K filings.
$438M in FY2024 with a 3-year CAGR of +14.7%.
Improved from $209M to $438M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +14.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#126 of 213 in Health CareTop 59% of 213This company $438.5M Sector average $2.5B
▼
-82.6% below sector average
Key checks
Key Insights
- 3-year CAGR of +14.7%, indicating consistent growth.
- In FY2024, current assets increased 64.5% year-over-year.
- Ranks #126 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $438.5M | +64.5% |
| FY2023 | $266.5M | +27.6% |
| FY2022 | $208.9M | -28.1% |
| FY2021 | $290.7M | -15.0% |
| FY2020 | $342.1M | - |
| FY2019 | - | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026